Volume: 9

1. Strengthen the prevention and control of Zika virus disease and other mosquito-borne infectious diseases in China Page:104—108
2. Efficacy and safety of peginterferon α-2b in treatment of HBeAg-positive chronic Hepatitis B Page:255—259
3. Advances in application of low-dose glucocorticoids in septic shock Page:284—288
4. Analysis of the hemolysin and virulence-related genes of incomplete hemolysis Staphylococcus aureus Page:236—242
5. Reduced antibiotics sensitivity of Acinetobaoter baumannii induced by meropenem in vitro and related mechanism Page:230—235
6. Case-case-control study of risk factors of carbapenem-resistant Acinetobacter baumannii infection Page:224—229
7. Clostridium difficile infection and prevention measures Page:213—223
8. Epidemiology and prevention of non-tuberculous mycobacteria infection Page:207—212
9. Distribution and antimicrobial resistance of coagulase-negative staphylococci isolated from cerebrospinal fluids in neurosurgical patients Page:355—358
10. Noninvasive models in diagnosis of liver fibrosis in patients with chronic hepatitis B Page:342—348
11. To promote studies on community-associated methicillin-resistant Staphylococcus aureus in China Page:294—298
12. National action plan on antimicrobial resistance:a great blueprint based on “One Health” Page:289—293
13. Research advances in new anti-HBV targets and related drugs Page:379—384
14. Advances in carbapenemase detection in Gram-negtive bacilli Page:248—254
15. Morphological characteristics of bone marrow in severe fever with thrombocytopenia syndrome:analysis of 28 cases Page:260—264
16. Time to positivity in differential diagnosis of intracranial infection caused by coagulase-negative Staphylococcus Page:518—521
17. Effect of cefuroxime axetil on vaginal microecological balance in mice Page:507—512
18. Xpert MTB/RIF assay in rapid diagnosis of tuberculous lymphadenitis Page:502—506
19. Risk factors of postoperative infection in liver transplantation patients Page:496—501
20. Efficacy and safety of alizarin combined with standard anti-tuberculosis therapy in treatment of multidrug-resistant pulmonary tuberculosis Page:265—269
21. Dynamic changes of PD-1 expression on CD4 + and CD8 + T cells in patients with HBeAg-positive chronic hepatitis B treated with telbivudine Page:486—490
22. Research progress on characteristics of Zika virus and its infection in human Page:109—115
23. Epidemiology and characteristics of antibacterial resistance in China Page:118—128
24. Antimicrobial stewardship and bacterial resistance in the intensive care unit Page:156—160,167
25. Prediction and identification of linear B-cell epitopes in the hemagglutinin of H7N9 avian influenza virus in human Page:336—341,348
26. Detection of membrane neutrophil alkaline phosphatase in diagnosis of infection in patients with acute cerebral hemorrhage Page:513—517,532
27. Bacterial resistance and human microecology Page:129—132
28. Importance of clinical microbiology laboratory in diagnosis and treatment of infectious diseases Page:133—136
29. Antimicrobial resistance surveillance system:construction and quality control Page:137—139
30. Toxicity of outer membrane vesicles derived from Acinetobacter baumannii strains with different drug-resistance spectrums Page:140—145
31. Construction and application of clinical microbiology laboratory data management expert system Page:161—167
32. Allele-31 C>T regulates binding activity to IL-1βgene promoter of nuclear transcription factor C/EBPβand PU.1 induced by Mycobacterium tuberculosis infection Page:180—185
33. Lipopolysaccharide preconditioning prevents incision infection induced by drug-resistant bacteria in mice Page:146—151
34. Direct identification of pathogens from positive blood cultures by matrix-assisted laser desorption ionization-time of flight mass spectrometry Page:152—155
35. Inhibitory effect of aminoglucomannan on human respiratory syncytial virus in vivo Page:173—179
36. Influenza vaccination in patients with systemic lupus erythematosus Page:547—550
37. Treatment advances of methicillin-resistant Staphylococcus aureus associated clinical infections Yuan Page:299—306
38. Chemotherapy for infections caused by carbapenem-resistant Gram-negative bacteria Page:307—313
39. Progress on pharmacokinetics/pharmacodynamics of antimicrobial agents Page:321—329
40. Molecular and phylogenetic analysis of human avian influenza A (H7N9) virus infection in Zhejiang province during 2013 and 2015 Page:330—335
41. Protective effect of histone deacetylase inhibitor MS-275 on acute liver failure induced by D-galactosamine and lipopolysaccharide in mice Page:349—354
42. Research progress on Epstein-Barr virus-associated hematological diseases Page:540—546
43. Clinical features of sporadic cases with H7N9 avian influenza in Taizhou city of Zhejiang province and characteristics of viral gene Page:491—495
44. Association between SLC10A1 genetic variations and suspectbility to hepatitis B virus infection by mother-to-child transmission Page:168—172,179